LINC01924

Across TCGA pan-cancer cohorts, LINC01924 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC01924 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC01924 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC01924 expression acts as an unfavorable survival marker, although some lineages such as COAD and MESO show a favorable association.

COAD, TGCT, and MESO are the cancer types where LINC01924 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Quartile	III,IV	0.874	0.610	.013	43	view →
TGCT	DFS	Tertile	II,III,IV	0.368	0.953	.001	36	view →
MESO	OS	Tertile	All	0.808	0.203	.004	27	view →
GBM	OS	Tertile	All	0.069	0.415	<.001	27	view →
KIRP	OS	Tertile	II,III,IV	0.667	0.892	.016	27	view →
KIRC	OS	Tertile	All	0.762	0.814	.040	21	view →
THCA	DFS	Tertile	All	0.788	0.918	.016	18	view →
READ	OS	Tertile	All	1.000	0.883	.012	18	view →
BLCA	OS	Quartile	All	0.617	0.380	.019	10	view →
BRCA	OS	Median	IV	0.914	0.567	.028	9	view →
THYM	OS	Tertile	II,III,IV	0.395	0.862	.047	6	view →
SKCM	DFS	Tertile	All	0.756	0.594	.033	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LINC01924–COAD (OS)

Open the COAD breakdown →